Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Shares Issued (2019 - 2025)

Revolution Medicines has reported Shares Issued over the past 7 years, most recently at -$2.8 million for Q3 2025.

  • Quarterly results put Shares Issued at -$2.8 million for Q3 2025, up 45.17% from a year ago — trailing twelve months through Dec 2025 was $4000.0 (down 99.97% YoY), and the annual figure for FY2025 was $4000.0, down 99.97%.
  • Shares Issued for Q3 2025 was -$2.8 million at Revolution Medicines, down from $2.8 million in the prior quarter.
  • Over the last five years, Shares Issued for RVMD hit a ceiling of $323.7 million in Q1 2023 and a floor of -$321.7 million in Q3 2023.
  • Median Shares Issued over the past 5 years was $257000.0 (2022), compared with a mean of $18.0 million.
  • Biggest five-year swings in Shares Issued: surged 1043266.67% in 2021 and later plummeted 154036.84% in 2023.
  • Revolution Medicines' Shares Issued stood at $356000.0 in 2021, then soared by 69400.56% to $247.4 million in 2022, then tumbled by 100.8% to -$2.0 million in 2023, then soared by 723.36% to $12.3 million in 2024, then crashed by 122.9% to -$2.8 million in 2025.
  • The last three reported values for Shares Issued were -$2.8 million (Q3 2025), $2.8 million (Q2 2025), and $1000.0 (Q1 2025) per Business Quant data.